Viewing Study NCT06921850

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2026-02-02 @ 6:52 AM
Study NCT ID: NCT06921850
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-04-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
Sponsor: UCB Biopharma SRL
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hidradenitis Suppurativa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bimekizumab View
None HS View
None Hidradenitis Suppurativa View